IRVINE, Calif., July 3, 2023 /PRNewswire/ — Helio Genomics, a leading developer of genomic AI early cancer detection tests, is proud to announce that its sister company, Laboratory for Advanced Medicine & Health Group (LAMH), has received approval from the National Medical Products…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.